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The finding that a single dose of nevirapine administered to
women during labour and to their infants after delivery
reduced mother-to-child transmission of human
immunodeficiency virus type 1 (HIV) by 47%1 was a critical
event. It made feasible the use of antiretrovirals for prevention
of mother-to-child transmission (PMTCT) of  HIV in poorly
resourced settings.2 Nevirapine has been provided as part of
routine care at Coronation Women and Children's Hospital
(CWCH) since April 2000.
CWCH is affiliated to the University of the Witwatersrand. It
provides primary, secondary and limited tertiary level obstetric
and neonatal care facilities to a large urban and peri-urban
population of western Johannesburg. Three district community
clinics provide antenatal care in the area. None of these clinics
provides intrapartum care, and only one had an established
voluntary counselling and testing (VCT) system at the time of
the first audit.  
Although simple, the nevirapine regimen poses several
challenges. It requires a functional VCT programme for HIV
during antenatal care. The window of opportunity for
intrapartum nevirapine is narrow — HIV-infected women
should receive nevirapine at least 2 hours before delivery to
ensure efficacy. Use of nevirapine before labour is problematic
because of evidence that nevirapine-resistant mutations of HIV
develop in approximately 20% of women3 and there are
concerns that the rate will be higher if multiple doses are used.
HIV-exposed infants should receive nevirapine within 48 - 72
hours of delivery. The logistics of providing nevirapine are
further complicated if, as occurs in our region, community
clinics provide antenatal but not intrapartum care, and may or
may not test for HIV.  
The objectives of the study were to describe deficiencies in
the antenatal VCT service and in provision of nevirapine, and
to assess changes following targeted interventions. 
Methods 
Audits were conducted in October 2000, April 2001 and
February 2002, and are referred to as audits 1, 2 and 3
respectively. Each audit was conducted over a 2-week period. It
comprised a retrospective review of hospital records and
antenatal clinic cards collected for consecutively discharged
patients from the postnatal wards at CWCH. Labour ward and
postnatal ward staff were not informed of the audit dates.
Information was collected regarding: (i) attendance at and site
of antenatal care; (ii) whether an HIV test was done; (iii)
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Objectives. Use of nevirapine for prevention of mother-to-child
transmission (PMTCT) of HIV-1 has been routine clinical care
at Coronation Women and Children's Hospital since April
2000.We assessed the effect of regular audit and targeted
interventions on the utilisation of the PMTCT programme. 
Methods. Review of antenatal cards and hospital records of
women discharged following delivery, in three time periods
between October 2000 and February 2002. Following the
initial audit an intervention was implemented to eliminate
weaknesses in our PMTCT service. Following the second
audit the hospital became a pilot site for the Gauteng PMTCT
programme.   
Results. In the initial audit 53.2% of women (159/299) were
tested for HIV and received their results, while 56% (14/25)
of identified HIV-infected women, and 16% (4/25) of their
infants, received nevirapine. By the third audit 74.3% of
women (266/358) received their results, and 86% (43/50) of
HIV-positive women and 74% (37/50) of newborns were
documented to have received nevirapine.  In all three audits
over 90% of women initiating antenatal care at the hospital
were tested for HIV, while women who initiated care at
district community clinics were less likely to receive testing.
Conclusions. Ongoing audit has been important for targeting
obstacles to detection of HIV-infected women and
documented nevirapine uptake by women and infants. Rates
of HIV testing and nevirapine use have increased
significantly. Voluntary counselling and testing for HIV and
use of nevirapine are acceptable to pregnant women in our
setting. Roll-out of the pilot programme to district community
clinics is essential for further improvement.   
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whether women received their HIV test result; (iv) whether a
rapid plasma reagin (RPR) test for syphilis was done (for
comparison purposes); and (v) whether nevirapine use was
documented for mother and infant. Antenatal cards and
hospital records of those not tested were assessed for missed
opportunities for VCT at CWCH.
Women initiating antenatal care at CWCH receive VCT, and
if they consent, are tested for HIV at the first visit. At the time
audit 1 was conducted a laboratory enzyme-linked
immunosorbent assay (ELISA) test was used. HIV-infected
women were identified at the second visit and referred to the
antenatal HIV clinic. One of the community clinics had a VCT
system, but the other clinics tested only sporadically. In the
interests of confidentiality results were documented cryptically
on the patient-held antenatal card. Each clinic had its own
method of documentation. HIV-infected women who presented
to the hospital in labour were identified by the nursing staff
and given nevirapine. In the postnatal wards, infants were
detected and treated in a similar manner.   
Problems with the operational aspects identified in the initial
audit (Table I) were addressed initially by means of an
intervention to increase staff awareness.  This included
discussions with relevant staff, and a poster campaign in the
hospital to target the problems identified. The audit was
repeated in April 2001, 2 months after the intervention.   
With the implementation of the national PMTCT pilot project
(described by McCoy et al.4) in October 2001, CWCH became a
provincial pilot site. Audit 3 was conducted in February 2002.
While the pilot project provided additional resources to the
hospital, the community clinics were not included. 
Statistical analysis was conducted using Epi-Info 2000. Audit
data were compared using a chi-square or Fisher's exact test as
appropriate. Audit 1 was used as a control group for audit 2,
and audit 2 for audit 3.
The study was approved by the University of the
Witwatersrand Committee for Research on Human Subjects,
protocol number M01-04-23. 
Results 
A total of 965 records were assessed across the three audits.
Audit data for the whole group, and for those initiating
antenatal care at CWCH, are presented in Tables II and III
respectively.  
The system for syphilis testing was efficient in all audits,
whether antenatal care was initiated at CWCH or elsewhere. A
total of 900/965 records (93.3%) had a rapid plasma reagin
(RPR) result documented. 
The rate of HIV testing differed markedly between women
who initiated antenatal care at CWCH and those who did not.
In total 424/965 women (43.9%) initiated antenatal care at
CWCH, forming a similar proportion in each audit. The rates
of testing for HIV among these subjects were above 90% for all
the audits, with 401/424 (94.5%) receiving HIV testing. 
Of the 965 women, 541 (56.0%) did not start antenatal care at
CWCH. Most of these subjects initiated antenatal care at the
community clinics, while 71 patients (7.4% of all subjects)
received no antenatal care. The rate of HIV testing among these
women was poor in audit 1, with only 37.2% (64/172) tested.
This improved to 64.1% (109/170) and 74.9% (149/199) in
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Table I. Process of audit and intervention
Changes introduced by PMTCT 
Problems at initial audit Probable reason/s for problem Interventions following audit 1 pilot project
Failure to offer Lack of VCT knowledge, Clinic staff informed about
VCT at community clinics skills and resources availability of VCT training
and encouraged to implement VCT 
Failure to test at hospital Lack of staff awareness Staff education Salaried lay counsellors
antenatal clinic visit 
Failure to obtain HIV results Lack of staff awareness Staff education ‘Rapid’ on-site tests
No maternal dose of Lack of staff awareness Staff education Women received nevirapine to take
nevirapine recorded OR Women presenting in home for  self-administration
advanced labour OR Difficulty 
interpreting encoded results 
OR Poor documentation
No infant dose of nevirapine Lack of staff awareness OR Staff education Lay counsellors
recorded Difficulty interpreting encoded monitor infant dosing
results OR Poor documentation
VCT = voluntary counselling and testing.
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audits 2 and 3 respectively. As there may have been missed
opportunities for testing at CWCH before the onset of labour,
the frequency of missed opportunities in untested women was
assessed in audits 1 and 2. There were 51 missed opportunities
in audit 1 compared with 24 in audit 2. 
The rate at which women received nevirapine increased
significantly between audits 1 and  3 (p = 0.004, chi-square).
The only women who received nevirapine to take home for
self-administration were those initiating antenatal care at
CWCH in audit 3. None of these women took their nevirapine
more than 48 hours before delivery. 
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Table II. HIV testing and nevirapine use for all patients
Audit 1 Audit 2 p-value* Audit 3 p-value*
October 2000 March 2001 (audit 2 v. February 2002 (audit 3 v.
(N = 299) (N = 308) audit 1) (N = 358) audit 2) 
HIV tested (No. (%)) 181 (60.5) 242 (78.6) < 0.001 300 (83.8) 0.08
HIV results obtained 159 (87.8) 213 (88.0) 0.95 266 (88.7) 0.81
antenatally (as % of
the tested)
ELISA-positive 27 (14.9) 58 (24.0) – 54 (18.0) –
(as % of tested)
Positive results obtained 25 (93) 51 (88) 0.79 50 (93) 0.41
antenatally (% of positives)
Mother received nevirapine 14 (56) 39 (76) 0.07 43 (86) 0.22
(as % of antenatal positives)
Nevirapine 2 - 48 hours Not checked 26 (67) – 30 (70) 0.76
before delivery (as % of 
those receiving nevirapine)
Baby received nevirapine 4 (16) 23 (45) 0.01 37 (74) 0.003
(as % of antenatal positives)
* Chi-square, or Fisher’s exact test. 
Table III. HIV testing and nevirapine use for subjects initiating antenatal care at CWCH
Audit 1 Audit 2 p-value* Audit 3 p-value*
October 2000 March 2001 (audit 2 v. February 2002 (audit 3 v. 
(N = 127) (N = 138) audit 1) (N = 159) audit 2)
HIV tested (No. (%)) 117 (92.1) 133 (96.4) 0.13 151 (95.0) 0.55
HIV results obtained 101 (86.3) 130 (97.7) <0.001 150 (99.3) 0.34
antenatally (as % of 
the tested)
ELISA-positive (as % 10 (8.5) 23 (17.3) - 24 (15.9) -
of the tested)
Positive results obtained 8  (80) 22 (96) 0.21 24 (100) 0.31
antenatally (% of 
positives)
Mother received 6 (75) 21 (95) 0.17 22 (92) 1.0
nevirapine (as % of 
antenatal positives)
Nevirapine 2 - 48 hours Not checked 14 (67) - 17 (77) 0.44
before delivery (as % of 
those receiving nevirapine)
Baby received nevirapine 1 (12.5) 7 (30) 0.39 19 (79) < 0.001
(as % of antenatal positives)
*Chi-square, or Fisher’s exact test . 
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Discussion 
The study demonstrates significant improvements over time in
the rates of testing for HIV. Audit 1 showed that the CWCH
antenatal clinic provided an effective VCT and HIV testing
programme for those initiating antenatal care at the hospital,
and demonstrates that HIV testing is well accepted by women
attending antenatal care.  Among women not initiating
antenatal care at CWCH the rate of HIV testing was low
because several community clinics did not have a well-
established VCT system. Testing rates improved over time, but
remained suboptimal.  The fact that RPR testing was provided
efficiently suggests that these clinics give competent antenatal
care, and that with appropriate support they should be able to
implement VCT for HIV. Although there was a reduction in
missed opportunities for HIV testing at CWCH, in many cases
there were no opportunities for HIV testing at the hospital. We
concur with the recommendation of McCoy et al.4 that the
PMTCT programme should be developed and integrated into
other related programmes at subdistrict level. 
The proportion of HIV tests for which results were obtained
did not improve between the audits, except among women
who initiated antenatal care at CWCH between audits 1 and 2.
For these patients virtually all results were obtained once staff
awareness improved, because undocumented results are
readily accessible by computer. Thus the introduction of a
rapid HIV test yielded no further improvement, contrary to the
findings of a previous study5 demonstrating increased uptake
of testing with a rapid test compared with a laboratory ELISA
test. The use of a rapid test would more likely have been useful
in the community clinics, where there were persistent problems
with obtaining HIV results.  
The maternal dose of nevirapine should be taken between 2
and 48 hours before delivery. Nearly one-third of women who
received nevirapine did not take it in this time period (i.e.
timeously). One might expect that women would tend to take
nevirapine too late if it is only dispensed by labour ward staff,
and too early if they self-administer it. However, in only one
case was the nevirapine taken too early and this was
administered by hospital staff. In the small group of subjects
who received nevirapine for self-administration there was no
significant improvement in the rate at which these women took
their nevirapine, or in the rate that they took it timeously. It is
likely that self-administration of nevirapine would be more
important for women who live further away from the hospital,
particularly those attending community clinics. Reasons for
failure to self-administer nevirapine at the correct time require
further elucidation. Our impression is that some women find it
difficult to decide when to take their nevirapine, or may
misplace the tablet. It is therefore important that women be
counselled on the correct use of nevirapine and that the labour
ward staff confirm that nevirapine has been taken.  
The emphasis on maternal diagnosis and prophylaxis may
result in an underemphasis on giving nevirapine to the infant.
However, this is an integral part of the regimen. In addition,
post-exposure prophylaxis with neonatal nevirapine may be
important if women do not receive nevirapine or do not receive
it timeously (G Gray et al. — paper presented at the 14th
International AIDS Conference, Barcelona, 2002 (abstract No.
LbOR13)). The neonatal dose of nevirapine was infrequently
documented at the initial audit. This improved, but by the
third audit neonatal nevirapine was still not documented in
one-quarter of cases. The neonatal dose is given in the
postnatal wards, and requires that the antenatal card and
delivery notes be rechecked and nevirapine given accordingly.  
The confidential nature of information regarding HIV status
unintentionally increases the risk of missed opportunities for
nevirapine use.  Some women are reluctant to notify staff of
their status. This is unlikely to change until stigma related to
HIV-positive status reduces. In addition, it has proved difficult
to develop a uniform but confidential system of documentation
for HIV results.  
The fact that almost half of the identified HIV-infected
women in audit 1 were not documented to have received
nevirapine may reflect poor documentation. The study was
limited by the fact that it relied on written documentation in
the antenatal cards and hospital records, and it was not
possible to differentiate with certainty between medication not
given and medication not documented. While we attempted to
improve documentation, we feel that for audit purposes it is
appropriate to assume that ‘not documented means not done’.
Another limitation was the retrospective collection of data,
resulting in an inability to collect information on women who
received antenatal care in our service but delivered elsewhere.  
It has been noted that public health interventions in
developing countries, such as the Expanded Programme for
Immunisation, have taken some time to achieve adequate
coverage.6 In view of our use of historical control groups, it is
not possible to be certain that the improvements documented
were due to the interventions applied rather than related to the
passage of time. However, it seems very likely that ongoing
quality control through audit and intervention has been
important in the improvement our PMTCT programme. It is
apparent from our results that the incremental effect of drop-
offs at several stages in the process of HIV testing, obtaining
results and providing nevirapine on the overall efficiency of
the PMTCT programme can be very large. Attention to each
detail is therefore essential. 
Conclusion  
The overall efficiency of our PMTCT service improved from
audit to audit. Testing for HIV and use of nevirapine were well
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accepted. The main shortcomings with HIV testing were
among women who initiated antenatal care outside the
hospital. Roll-out of the PMTCT pilot project to the community
clinics is essential. In addition, significant challenges remain in
the provision of nevirapine to newborns, and in the timing of
the maternal dose. Similar to many other public health
interventions, the PMTCT programme requires ongoing quality
control to ensure effectiveness. 
Our thanks to the hospital counselling staff, health workers, and
Professors K Bolton and S Levin.
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IN BRIEF
Domestic cleaning and asthma
Asthma is the most common occupational lung disease in industrialised countries, occupational exposures being responsible
for 5 - 20% of all adult asthma cases. Several community-based studies have recently shown an increased risk for asthma in
cleaners, an occupation not traditionally associated with this disease.
To assess the risk of asthma in women employed in domestic cleaning, a group of researchers in Spain conducted a cross-
sectional study in 4 521 women aged 30 - 65 years. Information on respiratory symptoms and cleaning work history was
obtained using a posted questionnaire, with telephonic follow-up. Asthma was defined as reported symptoms within the last
year, or current use of drugs to treat asthma. The questionnaire requested answers to questions about wheezing,
breathlessness, previous asthma, nocturnal dyspnoea, drug use for asthma, cough, phlegm, runny nose or sneezing without a
cold, and job-related respiratory problems.Work-related questions enquired about the location of the work (domestic or
non-domestic), timing and type of work.
Of the total enrolment, 593 of 4 521 women were employed as domestic cleaners. Asthma was more prevalent in this group
than in women who had never worked in cleaning. Former domestic work was reported by 1 170 women, and was strongly
associated with asthma. Current and former non-domestic cleaning was not significantly associated with asthma.Twenty-five
per cent of the asthma cases in the study population were attributable to domestic cleaning work.
This study suggests that not only professional domestic cleaners but people undertaking cleaning tasks at home are at risk of
asthma.
Medina-Ramon M et al.Thorax 2003; 58: 950-954.
